This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Trilink Biotechnologies, LLC, a for-profit limited liability company. The contract, valued at $4,422.10, is for the supply of CAS9 mRNA products to support NIAID's biomedical research efforts. Trilink Biotechnologies is a contract development and manufacturing organization that specializes in modified nucleic acids...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Trilink Biotechnologies, LLC, a for-profit limited liability company. The contract, worth $3,880.27, is for the supply of specialized biotechnology products such as modified nucleic acids, reagents, and oligonucleotides. These materials are used to support biomedical research and diagnostic applications,...
The U.S. Department of Health and Human Services (HHS) awarded a $4,456.00 firm-fixed-price purchase order to Trilink Biotechnologies, LLC, a small business, to provide in vitro RNA products. This contract was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, which was set aside for small businesses, has a completion date of February 15, 2016. Trilink Biotechnologies is a contract development and...
The federal government, specifically the Environmental Protection Agency's Office of Research and Development, has awarded a $41,419.60 firm-fixed-price purchase order contract to Lexogen Inc., a foreign-owned, for-profit company specializing in transcriptomics and next-generation sequencing technology. The contract is for the delivery of Lexogen Molecular Kits, which include products such as CorAll Prep Kits, QuantSeq 3' mRNA-Seq Library Prep Kits, Sense mRNA-Seq Library Prep Kits, and PCR...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $35,043 fixed-price purchase order to Trilink Biotechnologies, LLC of San Diego, California. The contract is for a standing order of N1-methyl-pseudoridine-5'-triphosphate and CleanCap reagent AG, to be delivered between August 2023 and May 2024. As part of its mission to conduct and support research on infectious and immune-mediated diseases, the National...
Lexogen Inc., a foreign-owned for-profit company specializing in transcriptomics and next-generation sequencing technology, was awarded a $39,293.72 firm-fixed-price purchase order by the Environmental Protection Agency's Office of Research and Development. The contract is for the delivery of Lexogen's molecular library preparation kits, such as CorAll Prep Kits, QuantSeq 3' mRNA-Seq Library Prep Kits, and Sense mRNA-Seq Library Prep Kits, which are used for analyzing water, soil, and biological...
The U.S. Environmental Protection Agency (EPA) Office of Research and Development awarded a $195,087 firm-fixed price purchase order to Novogene Corp Inc., a minority-owned small business, to provide transcriptomics (mRNA) analysis services for studying emerging contaminants in laboratory-exposed frog and fish tissues. The contract has a period of performance through March 31, 2025. This requirement was originally solicited as a total small business set-aside, with proposals due on December...
The Department of the Army Medical Command awarded a $10,505 firm fixed price call against its Basic Purchasing Agreement to Trilink Biotechnologies, LLC. The contract is for the delivery of PFCSP (M) CAP1 MRNA (WT) with an anticipated completion date of April 10, 2020. As the place of performance is listed as San Diego, California, it can be inferred the products or services will be delivered within the state. No set-aside designation was specified. Trilink Biotechnologies, LLC is the prime...
This is a federal contract award to Biospyder Technologies, Inc., a small business manufacturer specializing in genomic analysis services and products. The $78,178.92 firm fixed-price purchase order was awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development for RNA sequencing analysis. The contract supports the EPA's research efforts to understand environmental impacts on public health. Biospyder will provide targeted RNA sequencing (RNA-seq) analysis...
This award is for a firm fixed price Blanket Purchase Agreement (BPA) call task order from the U.S. Environmental Protection Agency (EPA) Office of Research and Development to Biospyder Technologies, Inc. (doing business as Biospyder), a for-profit small business manufacturer of genomic analysis services and products. The task order, titled "TRANSCRIPTOMICS PHASE 2," has a potential value of $158,124.96 and a completion date of April 19, 2020. This award is not set aside and is...